Chronic myelogenous leukemia in sickle cell anemia

Archives of Pathology and Laboratory Medicine

Volumn 129, Issue 3, 2005, Pages 423-424

  Chen, Lugen ^a   Zhuang, Minsheng ^a   Shah, Harshad Q ^a   Lin, Jen H ^a,b  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD SMEAR; CANCER RISK; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL EXAMINATION; COMORBIDITY; HUMAN; HUMAN CELL; MALE; RISK FACTOR; SICKLE CELL ANEMIA;

ADULT; ANEMIA, SICKLE CELL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE;

EID: 14844314866     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Philips G, Hartman J, Kinney TR, et al. Chronic granulocytic leukemia in a patient with sickle cell anemia. Am J Med. 1988;85:567-569.
2. Schultz WH, Ware RE. Malignancy in patients with sickle cell disease. Am J Hematol. 2003;74:249-253.
3. Aguiar RC. Therapy-related chronic myeloid leukemia; an epidemiological, clinical and pathogenetic appraisal. Leukemia Lymphoma. 1998;29:17-26.
4. Rauch A, Borromeo M, Ghafoor A, et al. Leukemogenesis of hydroxyurea in the treatment of sickle cell anemia [abstract]. Blood. 1999;94:415a.
5. Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003;289:1645-1651.